APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Crohn’s Disease Drug Industry Growth and Trends Forecast to 2032

Report ID 173981560122 December 202593 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Crohn’s Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Crohn’s Disease Drug include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Crohn’s Disease Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crohn’s Disease Drug market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crohn’s Disease Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crohn’s Disease Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Crohn’s Disease Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crohn’s Disease Drug Market by Company

Janssen Biotech

Takeda Pharmaceuticals

Amgen

AbbVie

Tillotts Pharma

Crohn’s Disease Drug Segment by Type

Aminosalicylates (5-ASA)

Antibiotics

Immunomodulators

Corticosteroids

Crohn’s Disease Drug Segment by Application

Pediatric Crohn'S Disease

Maintaining Remission (Prevention Of Flare-Ups)

Achieving Remission (The Absence Of Symptoms)

Crohn’s Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Crohn’s Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aminosalicylates (5-ASA) Table 2. Major Company of Antibiotics Table 3. Major Company of Immunomodulators Table 4. Major Company of Corticosteroids Table 5. Global Crohn’s Disease Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 7. Global Crohn’s Disease Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Crohn’s Disease Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Crohn’s Disease Drug Price by Type (2021-2026) & (US$/ton) Table 11. Global Crohn’s Disease Drug Sales by Type (2027-2032) & (k tons) Table 12. Global Crohn’s Disease Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Crohn’s Disease Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Crohn’s Disease Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Crohn’s Disease Drug Price by Type (2027-2032) & (US$/ton) Table 16. North America Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 17. North America Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 19. Europe Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 21. Asia-Pacific Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 23. Latin America Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 25. Middle East and Africa Crohn’s Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Crohn’s Disease Drug Industry Trends Table 27. Crohn’s Disease Drug Industry Drivers Table 28. Crohn’s Disease Drug Industry Opportunities and Challenges Table 29. Crohn’s Disease Drug Industry Restraints Table 30. Global Crohn’s Disease Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Crohn’s Disease Drug Revenue Market Share by Company (2021-2026) Table 32. Global Crohn’s Disease Drug Sales by Company (2021-2026) & (k tons) Table 33. Global Crohn’s Disease Drug Sales Share by Company (2021-2026) Table 34. Global Crohn’s Disease Drug Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Crohn’s Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Crohn’s Disease Drug Major Company Production Sites and Headquarters Table 37. Global Crohn’s Disease Drug Company, Product Type & Application Table 38. Global Crohn’s Disease Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Crohn’s Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Crohn’s Disease Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Crohn’s Disease Drug Sales by Region (2021-2026) & (k tons) Table 43. Global Crohn’s Disease Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Crohn’s Disease Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Crohn’s Disease Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Crohn’s Disease Drug Sales by Region (2027-2032) & (k tons) Table 48. Global Crohn’s Disease Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Crohn’s Disease Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Crohn’s Disease Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Crohn’s Disease Drug Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Crohn’s Disease Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 54. Global Crohn’s Disease Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Crohn’s Disease Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Crohn’s Disease Drug Price by Application (2021-2026) & (US$/ton) Table 58. Global Crohn’s Disease Drug Sales by Application (2027-2032) & (k tons) Table 59. Global Crohn’s Disease Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Crohn’s Disease Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Crohn’s Disease Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Crohn’s Disease Drug Price by Application (2027-2032) & (US$/ton) Table 63. North America Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 64. North America Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 66. Europe Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 68. Asia-Pacific Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 70. Latin America Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 72. Middle East and Africa Crohn’s Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Janssen Biotech Company Information Table 74. Janssen Biotech Business Overview Table 75. Janssen Biotech Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Janssen Biotech Crohn’s Disease Drug Product Portfolio Table 77. Janssen Biotech Recent Development Table 78. Takeda Pharmaceuticals Company Information Table 79. Takeda Pharmaceuticals Business Overview Table 80. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio Table 82. Takeda Pharmaceuticals Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Amgen Crohn’s Disease Drug Product Portfolio Table 87. Amgen Recent Development Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. AbbVie Crohn’s Disease Drug Product Portfolio Table 92. AbbVie Recent Development Table 93. Tillotts Pharma Company Information Table 94. Tillotts Pharma Business Overview Table 95. Tillotts Pharma Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Tillotts Pharma Crohn’s Disease Drug Product Portfolio Table 97. Tillotts Pharma Recent Development Table 98. North America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 99. North America Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 100. North America Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 101. North America Crohn’s Disease Drug Sales Forecast by Country (2027-2032) & (k tons) Table 102. North America Crohn’s Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 103. North America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Crohn’s Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Crohn’s Disease Drug Market Share by Country (2021-2026) Table 106. North America Crohn’s Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Crohn’s Disease Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 109. Europe Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 110. Europe Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 111. Europe Crohn’s Disease Drug Sales Forecast by Country (2027-2032) & (k tons) Table 112. Europe Crohn’s Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Crohn’s Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Crohn’s Disease Drug Market Share by Country (2021-2026) Table 116. Europe Crohn’s Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Crohn’s Disease Drug Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 120. Asia-Pacific Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Crohn’s Disease Drug Sales Forecast by Country (2027-2032) & (k tons) Table 122. Asia-Pacific Crohn’s Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Crohn’s Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Crohn’s Disease Drug Market Share by Country (2021-2026) Table 126. Asia-Pacific Crohn’s Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Crohn’s Disease Drug Market Share Forecast by Country (2027-2032) Table 128. Latin America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 129. Latin America Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 130. Latin America Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 131. Latin America Crohn’s Disease Drug Sales Forecast by Country (2027-2032) & (k tons) Table 132. Latin America Crohn’s Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Crohn’s Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Crohn’s Disease Drug Market Share by Country (2021-2026) Table 136. Latin America Crohn’s Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Crohn’s Disease Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 140. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Crohn’s Disease Drug Sales Forecast by Country (2027-2032) & (k tons) Table 142. Middle East and Africa Crohn’s Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Crohn’s Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Crohn’s Disease Drug Market Share by Country (2021-2026) Table 146. Middle East and Africa Crohn’s Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Crohn’s Disease Drug Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Crohn’s Disease Drug Distributors List Table 151. Crohn’s Disease Drug Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Crohn’s Disease Drug Image Figure 2. Global Crohn’s Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crohn’s Disease Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Crohn’s Disease Drug Sales (2021-2032) & (k tons) Figure 5. Aminosalicylates (5-ASA) Image Figure 6. Global Aminosalicylates (5-ASA) Sales YoY Growth (2021-2032) & (k tons) Figure 7. Antibiotics Image Figure 8. Global Antibiotics Sales YoY Growth (2021-2032) & (k tons) Figure 9. Immunomodulators Image Figure 10. Global Immunomodulators Sales YoY Growth (2021-2032) & (k tons) Figure 11. Corticosteroids Image Figure 12. Global Corticosteroids Sales YoY Growth (2021-2032) & (k tons) Figure 13. Global Crohn’s Disease Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Crohn’s Disease Drug Market Share by Type 2025 VS 2032 Figure 15. North America Crohn’s Disease Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Crohn’s Disease Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Crohn’s Disease Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Crohn’s Disease Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Crohn’s Disease Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Crohn’s Disease Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pediatric Crohn'S Disease Image Figure 28. Global Pediatric Crohn'S Disease Sales YoY Growth (2021-2032) & (k tons) Figure 29. Maintaining Remission (Prevention Of Flare-Ups) Image Figure 30. Global Maintaining Remission (Prevention Of Flare-Ups) Sales YoY Growth (2021-2032) & (k tons) Figure 31. Achieving Remission (The Absence Of Symptoms) Image Figure 32. Global Achieving Remission (The Absence Of Symptoms) Sales YoY Growth (2021-2032) & (k tons) Figure 33. Global Crohn’s Disease Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Crohn’s Disease Drug Market Share by Application 2025 VS 2032 Figure 35. North America Crohn’s Disease Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Crohn’s Disease Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Crohn’s Disease Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Crohn’s Disease Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Crohn’s Disease Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. North America Crohn’s Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Crohn’s Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Crohn’s Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Europe Crohn’s Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Crohn’s Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Crohn’s Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Asia-Pacific Crohn’s Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Crohn’s Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Crohn’s Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Latin America Crohn’s Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Crohn’s Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Crohn’s Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Crohn’s Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Middle East and Africa Crohn’s Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Crohn’s Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Crohn’s Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Crohn’s Disease Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Crohn’s Disease Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Aminosalicylates (5-ASA)
  • Antibiotics
  • Immunomodulators
  • Corticosteroids
Applications
  • Pediatric Crohn'S Disease
  • Maintaining Remission (Prevention Of Flare-Ups)
  • Achieving Remission (The Absence Of Symptoms)
Companies covered
  • Janssen Biotech
  • Takeda Pharmaceuticals
  • Amgen
  • AbbVie
  • Tillotts Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crohn’s Disease Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Crohn’s Disease Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Crohn’s Disease Drug Market by Type
  6. 1.3.1 Aminosalicylates (5-ASA)
  7. 1.3.2 Antibiotics
  8. 1.3.3 Immunomodulators
  9. 1.3.4 Corticosteroids
  10. 1.4 Global Crohn’s Disease Drug Market Size by Type
  11. 1.4.1 Global Crohn’s Disease Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Crohn’s Disease Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Crohn’s Disease Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Crohn’s Disease Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Crohn’s Disease Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Crohn’s Disease Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Crohn’s Disease Drug Industry Trends
  2. 2.2 Crohn’s Disease Drug Industry Drivers
  3. 2.3 Crohn’s Disease Drug Industry Opportunities and Challenges
  4. 2.4 Crohn’s Disease Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Crohn’s Disease Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Crohn’s Disease Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Crohn’s Disease Drug Price (2021-2026)
  4. 3.4 Global Crohn’s Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crohn’s Disease Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Crohn’s Disease Drug Company, Product Type & Application
  7. 3.7 Global Crohn’s Disease Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crohn’s Disease Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crohn’s Disease Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crohn’s Disease Drug Tier 1, Tier 2, and Tier 3
4 Crohn’s Disease Drug Regional Status and Outlook
  1. 4.1 Global Crohn’s Disease Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Crohn’s Disease Drug Historic Market Size by Region
  3. 4.2.1 Global Crohn’s Disease Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Crohn’s Disease Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Crohn’s Disease Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Crohn’s Disease Drug Forecasted Market Size by Region
  7. 4.3.1 Global Crohn’s Disease Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Crohn’s Disease Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Crohn’s Disease Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crohn’s Disease Drug by Application
  1. 5.1 Crohn’s Disease Drug Market by Application
  2. 5.1.1 Pediatric Crohn'S Disease
  3. 5.1.2 Maintaining Remission (Prevention Of Flare-Ups)
  4. 5.1.3 Achieving Remission (The Absence Of Symptoms)
  5. 5.2 Global Crohn’s Disease Drug Market Size by Application
  6. 5.2.1 Global Crohn’s Disease Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Crohn’s Disease Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Crohn’s Disease Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Crohn’s Disease Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Crohn’s Disease Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Crohn’s Disease Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Biotech
  2. 6.1.1 Janssen Biotech Company Information
  3. 6.1.2 Janssen Biotech Business Overview
  4. 6.1.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio
  6. 6.1.5 Janssen Biotech Recent Developments
  7. 6.2 Takeda Pharmaceuticals
  8. 6.2.1 Takeda Pharmaceuticals Company Information
  9. 6.2.2 Takeda Pharmaceuticals Business Overview
  10. 6.2.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio
  12. 6.2.5 Takeda Pharmaceuticals Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Crohn’s Disease Drug Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Crohn’s Disease Drug Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Tillotts Pharma
  26. 6.5.1 Tillotts Pharma Company Information
  27. 6.5.2 Tillotts Pharma Business Overview
  28. 6.5.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio
  30. 6.5.5 Tillotts Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Crohn’s Disease Drug Sales by Country
  2. 7.1.1 North America Crohn’s Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Crohn’s Disease Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Crohn’s Disease Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Crohn’s Disease Drug Market Size by Country
  6. 7.2.1 North America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Crohn’s Disease Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Crohn’s Disease Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Crohn’s Disease Drug Sales by Country
  2. 8.1.1 Europe Crohn’s Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Crohn’s Disease Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Crohn’s Disease Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Crohn’s Disease Drug Market Size by Country
  6. 8.2.1 Europe Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Crohn’s Disease Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Crohn’s Disease Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Crohn’s Disease Drug Sales by Country
  2. 9.1.1 Asia-Pacific Crohn’s Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Crohn’s Disease Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Crohn’s Disease Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Crohn’s Disease Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Crohn’s Disease Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Crohn’s Disease Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Crohn’s Disease Drug Sales by Country
  2. 10.1.1 South America Crohn’s Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Crohn’s Disease Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Crohn’s Disease Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Crohn’s Disease Drug Market Size by Country
  6. 10.2.1 South America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Crohn’s Disease Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Crohn’s Disease Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Crohn’s Disease Drug Sales by Country
  2. 11.1.1 Middle East and Africa Crohn’s Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Crohn’s Disease Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Crohn’s Disease Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Crohn’s Disease Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Crohn’s Disease Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Crohn’s Disease Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Crohn’s Disease Drug Value Chain Analysis
  2. 12.1.1 Crohn’s Disease Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Crohn’s Disease Drug Production Mode & Process
  7. 12.2 Crohn’s Disease Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Crohn’s Disease Drug Distributors
  10. 12.2.3 Crohn’s Disease Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst